Expression of BRCA1, HER-1 (EGFR) and HER-2 in sporadic breast cancer and relationships to other clinicopathological prognostic features.

Y. Ansquer(Hôpital Bichat-Claude-Bernard), Francine Walker(Hôpital Bichat-Claude-Bernard), C. Dhainaut(Université Claude Bernard Lyon 1), Laurent Mandelbrot(Hôpital Cochin), Thérèse Lehy(Inserm), Gérard Feldmann(Assistance Publique – Hôpitaux de Paris), Patrick Madélénat(Schiller International University), Laurence Salomon(French Clinical Research Infrastructure Network)
PubMed
January 25, 2006
Cited by 28


Related Papers